Bayer Proposes $2 Billion Settlement
Bayer Proposes Settling “Future” Roundup Cancer Claims for $2 Billion
Roundup Manufacturer proposes a $2 billion compensation program to pay damages to those who develop non-Hodgkin lymphoma after using Roundup.
To continue to contain its liability over claims that Roundup weedkiller causes cancer, Bayer has proposed creating a $2 billion compensation program to pay damages to farmers and gardeners who developed non-Hodgkin lymphoma after using Roundup.
The new proposal, which has been submitted for approval to the U.S. District in Northern California, would apply to claims filed in the next four years.
The German company has been battling litigation over Roundup’s safety since acquiring Monsanto Co., the weedkiller’s manufacturer, in 2018. After three separate California juries found in favor of plaintiffs who developed non-Hodgkin’s after using Roundup last June, Bayer agreed to pay up to $9.6 billion to settle existing Roundup cases.
Since taking over Monsanto, Bayer announced plans to invest $5.6 billion over the next decade in developing new weedkillers. However, in the meantime, it also continues to sell Roundup. Our firm continues to review and investigate cases where Roundup users later developed NHL.
Call Today!
We are accepting new RoundUp clients. Call us for a free case review! 419-241-1395 or 1-800-637-8170. Or contact us
